DOCTORS'
Medical Case Studies

present an adequate somatostatin receptor density. Also, myelosuppression as well as renal problems should not be underestimated after ... differentiation), non small cell lung cancers, myelosuppression, renal problems. Examinations : ...
entire group were 14.5 months, 33%, and 24%, respectively. Myelosuppression was the major toxicity (7). Another prospective trial ... neuroendocrine tumors, large cell neuroendocrine tumors, Myelosuppression, metastatic neuroendocrine carcinomas, NECs, ... neuroendocrine tumors, large cell neuroendocrine tumors, Myelosuppression, metastatic neuroendocrine carcinomas, NECs, ...
with the gain in survival. However, grade 3 and 4 myelosuppression and gastrointestinal toxicity are also increased. While no ... organ involvement, advanced endometrial cancer, myelosuppression, gastrointestinal toxicity, fluid retention, weight gain, ... organ involvement, advanced endometrial cancer, myelosuppression, gastrointestinal toxicity, fluid retention, weight gain, ...